Stay updated on RGX-111 Gene Therapy in MPS I Clinical Trial
Sign up to get notified when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.

Latest updates to the RGX-111 Gene Therapy in MPS I Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed, replacing the previous wording, and the revision version was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the banner about government funding-related updates; study details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check33 days agoChange DetectedThe screenshots show only cosmetic layout and formatting differences, with no changes to the main study details or outcomes.SummaryDifference0.5%

- Check62 days agoChange DetectedMajor update: page now includes government funding status notice and updated operating details, plus a new version tag v3.2.0. Removed a specific condition (Mucopolysaccharidosis type 1) and the old version tag.SummaryDifference4%

- Check69 days agoChange DetectedMinor corrections: standardize the medical condition name capitalization and bump the revision to v3.1.0.SummaryDifference0.2%

- Check83 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.SummaryDifference0.2%

Stay in the know with updates to RGX-111 Gene Therapy in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.